Jana M. Ellegast - Concepedia

Author

Jana M. Ellegast

Also Known As

Ellegast, Jana, Ellegast, Jana Maria, Ellegast, Jana, M, J. M. Ellegast, Jana Ellegast, Jana M Ellegast, Jana M. Ellegast, Jana Maria Ellegast

Publications

Citations

H-Index

Concepts

All Affiliations

Dana-Farber Cancer Institute Harvard University Broad Institute Boston Children's Hospital University Hospital of Zurich

About

Jana M. Ellegast is an author at Dana-Farber Cancer Institute specializing in medicine, systems biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	2.6K
2	Cell Biology	3	3	167
3	Engineering	1	1	2.4K
4	Health Sciences	1	1	78
5	Biochemistry	1	1	52

Jana M. Ellegast

Publications

Citations

H-Index

Page 1

	Year	Citations
5'-Triphosphate RNA Is the Ligand for RIG-I Veit Hornung, Jana M. Ellegast, Sarah Kim-Hellmuth, Science Viral ReplicationSystems BiologyEngineeringMolecular VirologyNeurovirology	2006	2.4K
Peripheral blood CD34+ cells efficiently engraft human cytokine knock-in mice Yasuyuki Saito, Jana M. Ellegast, Anahita Rafiei, Blood	2016	82
Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33 Ninel Azoitei, Christopher M. Hoffmann, Jana M. Ellegast, The Journal of Experimental Medicine Systems BiologyKras Mutant TumorsHsp90 InhibitorsMedicineReceptor Tyrosine Kinase	2012	78
RET-mediated autophagy suppression as targetable co-dependence in acute myeloid leukemia Saskia Rudat, Anja Pfaus, Ya‐Yun Cheng, Leukemia Hematological MalignancyCell AutophagyMixed-phenotype Acute LeukemiaAcute Myeloid LeukemiaMalignant Blood Disorder	2018	64
Identification of an allosteric benzothiazolopyrimidone inhibitor of the oncogenic protein tyrosine phosphatase SHP2 Jonathan R. LaRochelle, Michelle Fodor, Jana M. Ellegast, Bioorganic & Medicinal Chemistry BiochemistryMedicineReceptor Tyrosine KinaseMechanism Of ActionPharmacology	2017	52
Targeting acute myeloid leukemia dependency on VCP-mediated DNA repair through a selective second-generation small-molecule inhibitor Blandine Roux, Camille Vaganay, Jesse D. Vargas, Science Translational Medicine	2021	52
MPL expression on AML blasts predicts peripheral blood neutropenia and thrombocytopenia Philipp J. Rauch, Jana M. Ellegast, Corinne C. Widmer, Blood	2016	45
inv(16) and NPM1mut AMLs engraft human cytokine knock-in mice Jana M. Ellegast, Philipp J. Rauch, Larisa V. Kovtonyuk, Blood	2016	45
The ETS transcription factor ETV6 constrains the transcriptional activity of EWS–FLI to promote Ewing sarcoma Diana Lu, Jana M. Ellegast, Kenneth N. Ross, Nature Cell Biology	2023	40
Resistance Mechanisms to SYK Inhibition in Acute Myeloid Leukemia Anjali Cremer, Jana M. Ellegast, Gabriela Alexe, Cancer Discovery	2019	38

Page 1